ARTICLE | Company News
GeneCentric, Bristol-Myers Squibb deal
January 12, 2017 4:20 PM UTC
Bristol-Myers Squibb and GeneCentric partnered to explore the feasibility of using GeneCentric’s Cancer Subtype Platform (CSP) to identify translational biomarkers for cancer drug Opdivo nivolumab for...